Class information for:
Level 1: BZLF1//BRLF1//VIRAL MOL TUMOR DIAGNOST UNIT

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
7849 1243 40.3 67%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
668 12550 NASOPHARYNGEAL CARCINOMA//EPSTEIN BARR VIRUS//EBV

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BZLF1 Author keyword 23 64% 2% 23
2 BRLF1 Author keyword 11 78% 1% 7
3 VIRAL MOL TUMOR DIAGNOST UNIT Address 4 75% 0% 3
4 LYTIC CYCLE Author keyword 4 35% 1% 9
5 EA D Author keyword 3 100% 0% 3
6 GP350 Author keyword 3 60% 0% 3
7 BMRF1 Author keyword 2 67% 0% 2
8 EBV ACTIVATION Author keyword 2 67% 0% 2
9 GLYCOPROTEIN 350 Author keyword 2 67% 0% 2
10 PROGRAM BIOTECHNOL MED Address 2 25% 1% 7

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 BZLF1 23 64% 2% 23 Search BZLF1 Search BZLF1
2 BRLF1 11 78% 1% 7 Search BRLF1 Search BRLF1
3 LYTIC CYCLE 4 35% 1% 9 Search LYTIC+CYCLE Search LYTIC+CYCLE
4 EA D 3 100% 0% 3 Search EA+D Search EA+D
5 GP350 3 60% 0% 3 Search GP350 Search GP350
6 BMRF1 2 67% 0% 2 Search BMRF1 Search BMRF1
7 EBV ACTIVATION 2 67% 0% 2 Search EBV+ACTIVATION Search EBV+ACTIVATION
8 GLYCOPROTEIN 350 2 67% 0% 2 Search GLYCOPROTEIN+350 Search GLYCOPROTEIN+350
9 ZTA 2 15% 1% 10 Search ZTA Search ZTA
10 EBV REACTIVATION 2 33% 0% 4 Search EBV+REACTIVATION Search EBV+REACTIVATION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SWITCH GENE BZLF1 99 93% 3% 38
2 BZLF1 71 68% 5% 63
3 ZTA TRANSACTIVATOR 60 72% 4% 47
4 BZLF1 GENE PROMOTER 57 95% 2% 19
5 ZEBRA PROTEIN 49 82% 2% 28
6 EA D 47 86% 2% 24
7 BZLF1 PROTEIN 44 88% 2% 21
8 DISRUPT LATENCY 44 88% 2% 21
9 FACTOR R 40 72% 2% 31
10 TRANSACTIVATOR ZTA 34 93% 1% 13

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Regulation of the latent-lytic switch in Epstein-Barr virus 2014 9 93 76%
Lytic cycle switches of oncogenic human gammaherpesviruses 2007 61 55 71%
Regulation of Epstein-Barr virus reactivation from latency 2014 3 106 70%
Switching of EBV cycles between latent and lytic states 2014 3 116 67%
Virus and cell RNAs expressed during Epstein-Barr virus replication 2006 72 99 29%
Reactivation of Epstein-Barr virus from latency 2005 88 58 36%
Regulation of cellular and viral protein expression by the Epstein-Barr virus transcriptional regulator Zta Implications for therapy of EBV associated tumors 2009 10 104 63%
Latent and lytic Epstein-Barr virus replication strategies 2005 73 75 40%
bZIP proteins of human gammaherpesviruses 2003 51 68 50%
The need and challenges for development of an Epstein-Barr virus vaccine 2013 8 15 27%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 VIRAL MOL TUMOR DIAGNOST UNIT 4 75% 0.2% 3
2 PROGRAM BIOTECHNOL MED 2 25% 0.6% 7
3 VIROL CELL BIOL SECT 1 33% 0.2% 3
4 BIOMED SCI BIOSIGNALING 1 27% 0.2% 3
5 FRE 2854 1 19% 0.3% 4
6 UNITE BIOTECHNOL PATHOL 1 23% 0.2% 3
7 15 RUE RENE DESCARTES 1 50% 0.1% 1
8 ENDODONT ADV DENT TREATMENT 1 50% 0.1% 1
9 ESA 5082 1 50% 0.1% 1
10 FDN NEUROL C BESTA 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000270547 LMP1//LATENT MEMBRANE PROTEIN 1//EBV
2 0.0000164235 AUSTRALIAN VACCINE DEV TUMOUR IMMUNOL//EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 1//JOINT ONCOL PROGRAM
3 0.0000114005 ICP8//UL9//ALKALINE NUCLEASE
4 0.0000105687 MHV 68//MURINE GAMMAHERPESVIRUS//MURINE GAMMAHERPESVIRUS 68
5 0.0000091113 HERPESVIRUS SAIMIRI//KLIN MOL VIROL//STPC
6 0.0000089276 INFECTIOUS MONONUCLEOSIS//MONONUCLEOSIS//ACUTE EBV INFECTION
7 0.0000089080 LYMPHOEPITHELIOMA LIKE CARCINOMA//LYMPHOEPITHELIOMA//LYMPHOEPITHELIAL CARCINOMA
8 0.0000085283 CD21//COMPLEMENT RECEPTOR 2//CR2
9 0.0000073132 PRIMARY EFFUSION LYMPHOMA//KSHV//TUMOR VIROL PROGRAM
10 0.0000063531 SLAM ASSOCIATED PROTEIN SAP//ANTI CMV ANTIBODIES//VARICELLA ARTHRITIS